Skip to content
Clinical Trials – home
Therapeutic area

Endocrine disorders – page 13

  • 497 clinical trials
  • 183 recruiting
  • 211 conditions
  • 25 countries

Conditions in this area

211 conditions with trials, the busiest first

Clinical trials in Endocrine disorders

497 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

497 clinical trials

Precocious puberty+1

Recruiting

Study on Metformin and Lifestyle Changes for Girls with Early Puberty and Overweight

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Metformin Hydrochloride
  • Sponsor:Region Hovedstaden

Study on Reducing Cardiovascular Disease in Type 1 Diabetes Patients Using Finerenone and Semaglutide

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Steno Diabetes Center Copenhagen

Diabetic foot

Recruiting

Study on the Use of Plasma Rich in Growth Factors for Treating Foot Ulcers in Diabetic Patients with Peripheral Arterial Disease

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Platelet Concentrate
  • Sponsor:Biotechnology Institute I Mas D S.L.

Study on the Effects of Empagliflozin, Pioglitazone, and Semaglutide for Patients with Type 2 Diabetes

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Karolinska University Hospital

Study Comparing Sirolimus and Methylprednisolone for Patients with Active Thyroid Eye Disease

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Methylprednisolone
  • Sponsor:Helse Bergen HF

Neuroblastoma+1

Recruiting

Study on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Carboplatin
  • Sponsor:Princess Maxima Center For Pediatric Oncology

Study on the Effects of Metformin for Improving Muscle Function in Patients with Myotonic Dystrophy Type 1

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Hydrochloride
  • Sponsor:Assistance Publique Hopitaux De Paris

Thyroid cancer+2

Recruiting

Study Comparing Two Treatment Strategies for Intermediate-Risk Thyroid Cancer Using Sodium Iodide (131I) in Patients with Post-Surgery Evaluation

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Iodide (131I)
  • Sponsor:Centre Francois Baclesse

Study on ATX-01 for Adults Aged 18-64 with Myotonic Dystrophy Type 1 (DM1)

Investigational
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:16-Base Single Stranded Rna Targeting Mir-23B Linked To Oleic Acid
  • Sponsor:Arthex Biotech S.L.

Study on the Effectiveness of Denosumab for Treating Acute Charcot Foot in Diabetes Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Denosumab
  • Sponsor:Region Hovedstaden

Study on the Safety and Effects of Efpegerglucagon in Children Aged 2 and Older with Congenital Hyperinsulinism

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Efpegerglucagon
  • Sponsor:Hanmi Pharm. Co. Ltd.

Study Comparing Fluocinolone Acetonide and Dexamethasone Implants for Patients with Resistant Diabetic Macular Edema

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Centre Hospitalier Universitaire De Dijon

Substances studied in this area

The therapies tested most often in Endocrine disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.